Chugai Pharmaceutical
Clinical trials sponsored by Chugai Pharmaceutical, explained in plain language.
-
New hope for tough cancers: first patients test experimental drug
Disease control Recruiting nowThis is the first study in people to test a new drug called AUBE00 for advanced solid tumors. It aims to find a safe dose, see how the body processes the drug, and check for any early signs it might help shrink tumors. The study is for adults with certain advanced cancers who hav…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New hope for Tough-to-Treat lung cancer: first patients test experimental drug
Disease control Recruiting nowThis is the first study in people testing a new drug called ALPS12 for extensive stage small cell lung cancer that has returned after prior treatment. The main goals are to find a safe dose and see how the body handles the drug, while also checking for early signs that it might s…
Phase: PHASE1 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New drug trial offers hope for celiac patients who still suffer despite Gluten-Free diets
Disease control Recruiting nowThis study is testing whether an experimental drug called DONQ52 can help people with celiac disease who still experience intestinal damage and symptoms despite following a gluten-free diet. The trial will involve 92 participants who will receive either DONQ52 or a placebo for 27…
Phase: PHASE2 • Sponsor: Chugai Pharmaceutical • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC